TEV-56286 is named as a drug or biological intervention in 3 clinical trials in our USA trial register, 3 of which are recruiting. The lead sponsor is Teva Branded Pharmaceutical Products R&D LLC. Registered phases: Phase 2 and Phase 1. Conditions studied include Multiple System Atrophy; Healthy Volunteers.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06568237 | A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy (ClinicalTrials.gov ↗) Multiple System Atrophy |
Phase 2 | Recruiting |
| NCT07197866 | An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (ClinicalTrials.gov ↗) Multiple System Atrophy |
Phase 2 | Recruiting |
| NCT07674940 | A Trial to Assess TEV-56286 at Different Doses in Healthy Participants (ClinicalTrials.gov ↗) Healthy Volunteers |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Multiple System Atrophy | 2 |
| Healthy Volunteers | 1 |
| Lead sponsor | Trials |
|---|---|
| Teva Branded Pharmaceutical Products R&D LLC | 3 |
| Register | TEV-56286 trials |
|---|---|
| Clinical trials in USA | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how TEV-56286 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists TEV-56286 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.